![]() ![]() In recognition of his contributions to the study of cancer genetics, Dr. These powerful, sophisticated models closely recapitulate human disease, and have led to novel insights into tumor development, as well as new strategies for cancer detection and treatment. ![]() Jacks has pioneered the use of gene targeting technology in mice to study cancer-associated genes and to construct mouse models of many human cancer types, including cancers of the lung, pancreas, colon, thyroid, and soft tissue. The Jacks laboratory at MIT’s Koch Institute studies the genetic events underlying the development of cancer. He was a postdoctoral fellow with Robert Weinberg at the Whitehead Institute before joining the MIT faculty in 1992. Jacks received his bachelor’s degree in Biology from Harvard College, and his doctorate from the University of California, San Francisco, where he trained with Nobel Laureate Harold Varmus. From 2001 – 2007, he served as director of the Koch Institute’s predecessor, the MIT Center for Cancer Research, and was a long-standing Investigator of the Howard Hughes Medical Institute (1994-2021). ![]() Koch Professor of Biology and Co-director of the Ludwig Center for Molecular Oncology. He is the Founding Director of the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology, the David H. Tyler Jacks, the President of Break Through Cancer, has dedicated his life to cancer research. ![]()
0 Comments
Leave a Reply. |